[1] ÁLVAREZ-ERRICO D, VENTO-TORMO R, BALLESTAR E. Genetic and epigenetic determinants in autoinflammatory diseases[J]. Front Immunol,2017,8:318.
[2] PARK H, BOURLA A B, KASTNER D L, et al.Lighting the fires within:the cell biology of autoinflammatory diseases[J]. Nat Rev Immunol,2012,12(8):570-580.
[3] 李冀,宋红梅.自身炎症性疾病分类[J]. 协和医学杂志,2014,5(4):450-454. LI Ji, SONG Hongmei. Classification of inflammatory diseases[J]. Medical Journal of Peking Union Medical College Hospital,2014,5(4):450-454. (in Chinese)
[4] HOFFMAN H M, BRODERICK L. The role of the inflammasome in patients with autoinflammatory diseases[J]. J Allergy Clin Immunol,2016,138(1):3-14.
[5] TONG Y, DING Z H, ZHAN F X, et al. The NLRP3 inflammasome and stroke[J]. Int J Clin Exp Med,2015,8(4):4787-4794.
[6] KANG M J, JO S G, KIM D J, et al.NLRP3 inflammasome mediates interleukin-1beta production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice[J]. Immunology,2017,150(4):495-505.
[7] CUSH J J. Autoinflammatory syndromes[J]. Dermatol Clin,2013,31(3):471-480.
[8] AKSENTIJEVICH I, NOWAK M, MALLAH M, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory dis-ease (NOMID):a new member of the expanding family of pyrin-associated autoinflammatory diseases[J]. Arthritis Rheum,2012,46(12):3340-3348.
[9] EROGLU F K, KASAPCOPUR O, BESBASN, et al. Genetic and clinical features of cryopyrin-associated periodic syndromes in Turkish children[J]. Clin Exp Rheumatol,2016,34(6 Suppl 102):S115-S120.
[10] SARRABAY G, GRANDEMANGE S, TOUITOU I. Diagnosis of cryopyrin-associated periodic syndrome:challenges, recommendations and emerging concepts[J]. Expert Rev Clin Immunol,2015,11(7):827-835.
[11] NAKAGAWA K, GONZALEZ-ROCA E, SOUTO A, et al. Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes[J]. Ann Rheum Dis,2015,74(3):603-610.
[12] MENSA-VILARO A, TERESA B M, MAGRI G, et al. Brief report:late-onset cryopyrin-associated periodic syndrome due to myeloid-restricted somatic NLRP3 mosaicism[J]. Arthritis Rheumatol,2016,68(12):3035-3041.
[13] BRODERICK L, DE NARDO D, FRANKLIN B S, et al. The inflammasomes and autoinflammatory syndromes[J]. Annu Rev Pathol,2015,10:395-424.
[14] NAZ V E, CARO G D, PINEDOi M F, et al. Muckle-Wells syndrome:a case report with an NLRP3 T348M mutation[J]. Pediatr Dermatol,2016,33(5):e311-e314.
[15] HU J, ZHU Y, ZHANG J Z, et al. A novel mutation in the pyrin domain of the NOD-like receptor family pyrin domain containing protein 3 in Muckle-Wells syndrome[J]. Chin Med J (Engl),2017,130(5):586-593.
[16] STOJANOV S, WEISS M, LOHSE P, et al. A novel CIAS1 mutation and plasma/cerebrospinal fluid cytokine profile in a German patient with neonatal-onset multisystem inflammatory disease responsive to methotrexate therapy[J]. Pediatrics,2004,114(1):e124-e127.
[17] YU J R, LESLIE K S. Cryopyrin-associated periodic syndrome:an update on diagnosis and treatment response[J]. Curr Allergy Asthma Rep,2011,11(1):12-20.
[18] FINETTI M, OMENETTI A, FEDERICI S, et al. Chronic infantile neurological cutaneous and articular (CINCA) syndrome:a review[J]. Orphanet J Rare Dis,2016,11(1):167-177.
[19] NEVEN B, PRIEUR A M, QUARTIER DIT MAIRE P. Cryopyrinopathies:update on pathogenesis and treatment[J]. Nat Clin Pract Rheumatol,2008,4(9):481-489.
[20] ALGHAMDI M. Familial Mediterranean fever, review of the literature[J]. Clin Rheumatol,2017,36(8):1707-1713.
[21] REPA A, BERTSIAS G K, PETRAKI E, et al. Dysregulated production of interleukin-1beta upon activation of the NLRP3 inflammasome in patients with familial Mediterranean fever[J]. Hum Immunol,2015,76(7):488-495.
[22] MITROULIS I, KOURTZELIS I, KAMBAS K, et al. Evidence for the involvement of mTOR inhibition and basal autophagy in familial Mediterranean fever phenotype[J]. Hum Immunol,2011,72(2):135-138.
[23] TIMERMAN D, FRANK N Y. Novel double heterozygous mutations in MEFV and NLRP3 genes in a patient with familial Mediterranean fever[J]. J Clin Rheumatol,2013,19(8):452-453.
[24] CHAE J J, CHO Y H, LEE G S, et al. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice[J]. Immunity,2011,34(5):755-768.
[25] MANUKYAN G, PETREK M, NAVRATILOVA Z, et al. Transcriptional activity of neutrophils exposed to high doses of colchicine:short communication[J]. J Biol Regul Homeost Agents,2015,29(1):125-130.
[26] BEN-ZVI I, KUKUY O, GIAT E, et al. Anakinra for colchicine-resistant familial mediterranean fever:a randomized, double-blind, placebo-controlled trial[J]. Arthritis Rheumatol,2017,69(4):854-862.
[27] HERSH A O, PRAHALAD S. Immunogenetics of juvenile idiopathic arthritis:a com prehensive review[J]. J Autoimmun,2015,64(1):113-124.
[28] TADAKI H, SAITSU H, NISHIMURA-TDAKI A, et al. De novo 19q13.42 duplications involving NLRP gene cluster in a patient with systemic-onset juvenile idiopathic arthritis[J]. J Hum Genet,2011,56(5):343-347.
[29] HAYEM F, HAYEM G. Still's disease and the mitochondrion:the other face of an old friend?[J]. Med Hypotheses,2012,79(2):136-137.
[30] OHNISHI H, TERAMOTO T, IWATA H, et al. Characterization of NLRP3 variants in Japanese cryopyrin-associated periodic syndrome patients[J]. J Clin Immunol,2012,32(2):221-229.
[31] YANG C A, HUANG S T, CHANG B L. Association of NLRP3 and CARD8 genetic polymorphisms with juvenile idiopathic arthritis in a Taiwanese population[J]. Scand J Rheumatol,2014,43(2):146-152.
[32] DAY T G, RAMANAN A V, HINKS A, et al. Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis[J]. Arthritis Rheum,2008,58(7):2142-2146.
[33] LAMOT L, BOROVECKI F, TAMBIC B L, et al. Aberrant expression of shared master-key genes contributes to the immunopathogenesis in patients with juvenile spondyloarthritis[J/OL]. PLoS One,2014,9(12):e115416.
[34] HORNEFF G, PEITZ J, KEKOW J, et al.Canakinumab for first line steroid-free treatment in a child with systemic-onset juvenile idiopathic arthritis[J]. Scand J Rheumatol,2017:1-2.
[35] LORDEN G, GARCIA S I, PABLO N, et al. Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation[J]. Exp Med,2017,214(2):511-528.
[36] SCIANARO R, INSALACO A, LAUDIERO L B, et al. Deregulation of the IL-1β axis in chronic recurrent multifocal osteomyelitis[J]. Pediatr Rheumatol,2014,12(30):1-6.
[37] HERLIN T, FⅡGAARD B, BJERRE M, et al.Efficacy of anti-IL-1 treatment in Majeed syndrome[J]. Ann Rheum Dis,2013,72(3):410-413.
[38] SHOHAM N G, CENTOLA M, MANSFIELD E, et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway[J]. Proc Natl Acad Sci U S A,2003,100(23):13501-13506.
[39] CAORSI R, PICCO P, BUONCOMPAGNI A, et al. Osteolytic lesion in PAPA syndrome responding to anti-interleukin 1 treatment[J]. J Rheumatol,2014,41(11):2333-2334.
[40] SALSANOL E, RIZZO A, BEDINI G, et al. An autoinflammatory neurological disease due to interleukin 6 hypersecretion[J]. J Neuroinflammation,2013,10(1):29-36.
[41] LOOCK J, LAMPRECHT P, TIMMANN C, et al. Genetic predisposition (NLRP3 V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome[J]. J Allergy Clin Immunol,2010,125(2):500-502.